Cardlytics (NASDAQ:CDLX) Releases Quarterly Earnings Results, Beats Expectations By $0.18 EPS

Cardlytics (NASDAQ:CDLX) issued its earnings results on Wednesday. The company reported ($0.15) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.18, Briefing.com reports. Cardlytics had a negative return on equity of 17.96% and a negative net margin of 50.21%. The company had revenue of $67.06 million for the quarter, compared to analyst estimates of $57.77 million. During the same period in the prior year, the firm earned ($0.26) earnings per share. Cardlytics’s revenue for the quarter was down 15.1% on a year-over-year basis. Cardlytics updated its Q4 2024 guidance to EPS.

Cardlytics Stock Performance

Shares of CDLX stock traded up $0.30 during trading on Friday, hitting $4.37. The company’s stock had a trading volume of 1,752,101 shares, compared to its average volume of 1,242,283. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 1.01. The company has a market cap of $217.80 million, a PE ratio of -1.14 and a beta of 1.61. The business has a fifty day moving average of $3.69 and a 200-day moving average of $6.70. Cardlytics has a 52 week low of $2.89 and a 52 week high of $20.52.

Insider Buying and Selling

In other Cardlytics news, CEO Amit Gupta sold 22,607 shares of the company’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $3.85, for a total value of $87,036.95. Following the completion of the transaction, the chief executive officer now owns 178,519 shares in the company, valued at $687,298.15. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Cardlytics news, CEO Amit Gupta sold 22,607 shares of the business’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $3.85, for a total value of $87,036.95. Following the transaction, the chief executive officer now directly owns 178,519 shares in the company, valued at $687,298.15. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Scott A. Hill bought 40,000 shares of Cardlytics stock in a transaction dated Monday, August 12th. The shares were bought at an average cost of $3.58 per share, with a total value of $143,200.00. Following the completion of the transaction, the director now directly owns 40,000 shares in the company, valued at approximately $143,200. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 43,573 shares of company stock worth $151,612. 4.40% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CDLX. Bank of America downgraded shares of Cardlytics from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $4.00 to $3.50 in a report on Thursday, August 15th. Northland Capmk lowered Cardlytics from a “strong-buy” rating to a “hold” rating in a report on Friday, August 16th. Evercore ISI assumed coverage on Cardlytics in a report on Friday, October 11th. They issued an “in-line” rating and a $4.00 target price on the stock. Lake Street Capital cut Cardlytics from a “buy” rating to a “hold” rating and cut their target price for the company from $18.00 to $5.00 in a research report on Thursday, August 8th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research report on Thursday. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $6.92.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.